We are live on ! Find out more
MRM

Michael R. Murphy Portfolio holdings

AUM $255M
1-Year Est. Return 0.87%
This Fund
S&P 500
This Quarter Est. Return
-15.54%
1 Year Est. Return
+0.87%
3 Year Est. Return
+93.92%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$291M
AUM Growth
-$27.9M
Cap. Flow
+$35M
Cap. Flow %
12.02%
Top 10 Hldgs %
67.95%
Holding
27
New
4
Increased
11
Reduced
8
Closed
3

Top Buys

Rank Stock Value
1
FMI
Foundation Medicine, Inc.
FMI
+$27.1M
2
SQI
SCIQUEST, INC. COMMON STOCK
SQI
+$15.1M
3
TUBE
TubeMogul, Inc.
TUBE
+$12.6M
4
ONTO icon
Onto Innovation
ONTO
+$8.12M
5
IMPR
IMPRIVATA, INC COM
IMPR
+$7.34M

Top Sells

Rank Stock Value
1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$15.7M
2
IL
IntraLinks Holdings Inc.
IL
+$11.6M
3
MRCY icon
Mercury Systems
MRCY
+$8.88M
4
YDLE
YODLEE INC COMMON STOCK
YDLE
+$8.82M
5
EXA
EXA Corporation
EXA
+$7.73M

Sector Composition

Rank Sector Weight
1 Technology 59.09%
2 Healthcare 19.84%
3 Miscellaneous 10.98%
4 Real Estate 5.06%
5 Consumer Discretionary 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YDLE
26
DELISTED
YODLEE INC COMMON STOCK
YDLE
– –
-611,092
Closed -$8.82M
BRLI
27
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
– –
-103,271
Closed -$4.26M
1
2

Similar funds

3I
3I Investments London Swie 5jd, United Kingdom $259M AUM 10.04% 1-Year Est. Return
PTA
Pear Tree Advisors Lincoln, Massachusetts $238M AUM 3.59% 1-Year Est. Return
DAM
Deimos Asset Management Purchase, New York $229M AUM
IMAS
ID Management A/S Randers, Denmark $316M AUM 0.73% 1-Year Est. Return
ACMM
Arbor Capital Management (Minnesota) Minneapolis, Minnesota $190M AUM 10.8% 1-Year Est. Return
AAM
Aston Asset Management Chicago, Illinois $164M AUM 2.95% 1-Year Est. Return
RDM
Retirement Design & Management Westport, Connecticut $160M AUM 4.3% 1-Year Est. Return
FNB
First Niagara Bank Lockport, New York $350M AUM 7.06% 1-Year Est. Return

Michael R. Murphy's Q3 2015 Portfolio in Review

As of Q3 2015, Michael R. Murphy held 27 positions worth $291M, down 8.8% from $319M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Michael R. Murphy deployed $35M of net new capital in Q3 2015, opening 4 new positions and adding to 11 existing holdings. Its largest new stake was Foundation Medicine, Inc.: 1,084,393 shares worth $20M.

By sector, the portfolio is most concentrated in Technology at 59% of assets, up from 54% a quarter earlier, followed by Healthcare and Miscellaneous.

On the sell side, the largest reduction was Supernus Pharmaceuticals, an estimated $15.7M trimmed.

  • Michael R. Murphy's largest Q3 2015 buy was Foundation Medicine, Inc.: 1,084,393 shares worth $20M.
  • Michael R. Murphy added most to TubeMogul, Inc. in Q3 2015, an estimated $12.6M increase.
  • Michael R. Murphy's biggest Q3 2015 reduction was Supernus Pharmaceuticals, cutting an estimated $15.7M.
  • Michael R. Murphy fully exited Mercury Systems in Q3 2015, selling an estimated $8.88M.
  • Michael R. Murphy's ten largest holdings make up 68% of its $291M portfolio in Q3 2015.
  • Michael R. Murphy opened 4 new positions and closed 3 in Q3 2015.
  • Michael R. Murphy's portfolio value fell 8.8% quarter-over-quarter to $291M.

Based on Michael R. Murphy's 13F filing for Q3 2015, filed 13 Nov 2015.